← Leaderboards
James Thomas Payne
Stanford University
$178,478
Attributed
$178,478
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $63.7K · FY2017–19$100K$75K$50K$25K$0
'17
'18
'19
Funding mix
By agency
NIH$178,478 · 1
By mechanism
F32$178,478 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Elizabeth Susan Sattely$6,246,816
- Heike Elizabeth Daldrup-Link$23,256,656
- Chaitan Khosla$26,183,068
- Brian K Kobilka$34,154,790
- Jimmy Wu$3,083,877
Others in their field
Other Emerging Leaders on “Property”
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Susan Abushakra · Alzheon, Inc.$47,265,244
- John Hobbs · Suny At Stony Brook$42,194,917
- Christopher Bee · Suny At Stony Brook$41,239,084
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,689,447
- Eric C Palm · Florida State University$35,115,872
Research focus
PropertySynthetic BiologyTrainingTyrosineTyrosine AnalogYeastsAlanineAlkaloidsAnabolismAnalogAnticancer ActivityAntitussive AgentsBenzylisoquinolinesBiologicalCombinatorialDesignDockingDrug DevelopmentEngineeringEnzyme BiosynthesisEnzyme PathwayEnzymesEscherichia ColiFeeding
Grant awards (3)
Enzyme and Pathway Engineering for in vivo Production of Anticancer Noscapine Derivatives$63,746
F32 · FY2019 · AT · contact PI
Enzyme and Pathway Engineering for in vivo Production of Anticancer Noscapine Derivatives$58,038
F32 · FY2018 · AT · contact PI
Enzyme and Pathway Engineering for in vivo Production of Anticancer Noscapine Derivatives$56,694
F32 · FY2017 · AT · contact PI